MAPT and Alzheimer disease: The progressive cognitive impairment and decline in patients suffering from Alzheimer’s Disease (AD) is believed to arise from the accumulation of amyloid-beta (Aβ) in the form of amyloid plaques and tau neurofibrillary tangles (NFTs) [1, 2] and is thought to characterize AD.